Craneware Stock
Craneware plc
Company data
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Country
- United Kingdom
- CEO
- Keith Neilson
- Employees
- 765
- Market cap
- £375 M
- IPO
- 13/09/2007
Craneware plc, with its associated entities, is dedicated to creating, distributing, and maintaining cutting-edge software applications tailored for the U.S. healthcare industry. Its extensive suite of products is designed to streamline and improve a wide array of operational functions for healthcare organizations.…
Craneware stock: price history
1D
-0.9%
1W
-0.5%
1M
-14.7%
6M
-27.6%
YTD
-43.3%
1Y
-54.2%
2Y
-44.2%
5Y
-53.2%
10Y
-13.9%
Next earnings date
Next earnings date
08/03/2027 (in 142 days)
Volatility around earnings
~67% stronger price swings than usual
Ask the agents about Craneware
Craneware stock metrics
P/E
26.04
P/B
1.54
EV/EBITDA
7.96
RETURN ON EQUITY
3.0%
NET MARGIN
9.7%
DEBT/EQUITY
0.15
DIVIDEND YIELD
3.1%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
73.8%
FLOAT SHARES
25,266,827
AVG. DAILY VOLUME (30D)
281,030
Dividends
Comparable stocks
Frequently asked questions about Craneware stock
What does Craneware do?
Craneware plc is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in United Kingdom.
The CEO is Keith Neilson, the company employs around 765 people.
The IPO was on 13/09/2007; the stock trades on LSE under the ticker CRW.L.
When does Craneware report next?
The next earnings date is 08/03/2027.
Around past earnings, price swings were roughly 67% stronger than usual.
Does Craneware pay a dividend?
Yes. The last dividend was £17.00 per share, ex-date 03/12/2026, paid on 22/12/2026.
The dividend yield is 3.1% (as of 30/06/2026).
Which stocks are comparable to Craneware?
Comparable stocks include Optima Health, Hinge Health, HealthEquity, Heartflow, Omada Health, Teladoc Health, SOPHiA GENETICS and Evolent Health.
How can I get Craneware stock analyzed?
Clicking "Analyze stock" lets five strategies assess Craneware against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.